Efficacy, safety and pharmacokinetics of ilaprazole infusion in healthy subjects and patients with esomeprazole as positive control
Author:
Affiliation:
1. Clinical Pharmacology Research CenterPeking Union Medical College Hospital Beijing China
2. Jiangsu Province Hospital Nanjing Jiangsu China
3. Livzon Pharmaceutical Group Inc Zhuhai Guangdong China
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14076
Reference23 articles.
1. Management of Gastroesophageal Reflux Disease
2. Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression
3. Proton pump inhibitors: the beginning of the end or the end of the beginning?
4. General pharmacology of IY‐81149, a new proton pump inhibitor;Kim EJ;Arzneimittelforschung,2001
5. Ilaprazole, a new proton pump inhibitor, is primarily metabolized to ilaprazole sulfone by CYP3A4 and 3A5
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Computational drug–drug interaction prediction mediated by CYP450 isoforms of Ilaprazole coadministered with clopidogrel;Future Science OA;2024-05-17
2. Population pharmacokinetic modeling of ilaprazole in healthy subjects and patients with duodenal ulcer in China;Frontiers in Pharmacology;2024-01-10
3. Efficacy and safety of high-dose ilaprazole-amoxicillin dual therapy for Helicobacter pylori eradication: a prospective, single-center, randomized trial;Frontiers in Pharmacology;2023-11-07
4. Ilaprazole-amoxicillin dual therapy at high dose as a first-line treatment for helicobacter pylori infection in Hainan: a single-center, open-label, noninferiority, randomized controlled trial;BMC Gastroenterology;2023-07-24
5. Newer, Older, and Alternative Agents for the Eradication of Helicobacter pylori Infection: A Narrative Review;Antibiotics;2023-05-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3